The  	The  	 DT	O
impact  	impact  	 NN	O
of  	of  	 IN	O
RTOG  	RTOG  	 NNP	B-NP
0614  	0614  	 CD	O
and  	and  	 CC	O
RTOG  	RTOG  	 NNP	B-NP
0933  	0933  	 CD	O
trials  	trials  	 NNS	O
in  	in  	 IN	O
routine  	routine  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
practice 	practice 	 NN	I-NP
:  	:  	 :	O
The  	The  	 DT	O
US  	US  	 NNP	O
Survey  	Survey  	 NNP	O
of  	of  	 IN	O
Utilization  	Utilization  	 NN	O
of  	of  	 IN	O
Memantine  	Memantine  	 NNP	B-NP
and  	and  	 CC	O
IMRT  	IMRT  	 NNP	B-NP
planning  	planning  	 NN	I-NP
for  	for  	 IN	I-NP
hippocampus  	hippocampus  	 JJ	I-NP
sparing  	sparing  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	O
whole  	whole  	 JJ	O
brain  	brain  	 NN	O
radiotherapy  	radiotherapy  	 NN	O
for  	for  	 IN	O
brain  	brain  	 NN	O
metastases  	metastases  	 VBD	O
Two  	Two  	 CD	O
recent  	recent  	 JJ	O
clinical  	clinical  	 JJ	B-NP
trials 	trials 	 NNS	I-NP
,  	,  	 ,	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
RTOG  	RTOG  	 NNP	B-NP
0614  	0614  	 CD	O
and  	and  	 CC	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
RTOG  	RTOG  	 NNP	B-NP
0933 	0933 	 CD	O
,  	,  	 ,	O
showed  	showed  	 VBD	O
some  	some  	 DT	O
effectiveness  	effectiveness  	 NN	O
of  	of  	 IN	O
Memantine  	Memantine  	 NNP	B-NP
and  	and  	 CC	O
IMRT  	IMRT  	 NNP	B-NP
planning  	planning  	 NN	I-NP
for  	for  	 IN	I-NP
hippocampus  	hippocampus  	 JJ	I-NP
sparing 	sparing 	 NN	I-NP
,  	,  	 ,	O
among  	among  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	O
whole  	whole  	 JJ	B-NP
brain  	brain  	 NN	I-NP
radiotherapy  	radiotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
WBRT 	WBRT 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
brain  	brain  	 NN	B-NP
metastases 	metastases 	 NNS	I-NP
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
their  	their  	 PRP$	O
use  	use  	 NN	O
in  	in  	 IN	O
routine  	routine  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
practice  	practice  	 NN	I-NP
is  	is  	 VBZ	O
unknown 	unknown 	 JJ	O
.  	.  	 .	O
A  	A  	 DT	O
survey  	survey  	 NN	O
was  	was  	 VBD	O
sent  	sent  	 VBN	O
to  	to  	 TO	O
1933  	1933  	 CD	O
radiation  	radiation  	 NN	B-NP
oncologists  	oncologists  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
US 	US 	 NNP	O
.  	.  	 .	O
Data  	Data  	 NNP	O
collected  	collected  	 VBD	O
included  	included  	 VBN	B-NP
utilization  	utilization  	 NN	I-NP
of  	of  	 IN	I-NP
Memantine  	Memantine  	 NNP	I-NP
and  	and  	 CC	O
hippocampus  	hippocampus  	 JJ	B-NP
sparing 	sparing 	 NN	I-NP
,  	,  	 ,	O
reasons  	reasons  	 NNS	O
for  	for  	 IN	O
adoption  	adoption  	 NN	O
and  	and  	 CC	O
non-adoption 	non-adoption 	 JJ	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
demographic  	demographic  	 JJ	B-NP
variables 	variables 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
196  	196  	 CD	O
radiation  	radiation  	 NN	B-NP
oncologists  	oncologists  	 NNS	I-NP
responded  	responded  	 VBD	O
to  	to  	 TO	O
the  	the  	 DT	O
survey 	survey 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
64 	64 	 CD	O
%  	%  	 NN	O
reporting  	reporting  	 NN	O
using  	using  	 VBG	O
Memantine  	Memantine  	 NNP	B-NP
in  	in  	 IN	O
almost  	almost  	 RB	O
none  	none  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	B-NP
WBRT  	WBRT  	 NNP	I-NP
for  	for  	 IN	I-NP
brain  	brain  	 NN	I-NP
metastases 	metastases 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
only  	only  	 RB	O
11 	11 	 CD	O
%  	%  	 NN	O
considering  	considering  	 VBG	B-NP
Memantine  	Memantine  	 NNP	I-NP
for  	for  	 IN	O
< 	< 	 SYM	O
10 	10 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
reason  	reason  	 NN	O
for  	for  	 IN	O
not  	not  	 RB	O
using  	using  	 VBG	O
Memantine  	Memantine  	 NNP	B-NP
was  	was  	 VBD	O
a  	a  	 DT	O
poor  	poor  	 JJ	O
patient  	patient  	 NN	O
performance  	performance  	 NN	O
status 	status 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
limited  	limited  	 JJ	O
life  	life  	 NN	B-NP
expectancy 	expectancy 	 NN	I-NP
.  	.  	 .	O
Likewise 	Likewise 	 RB	O
,  	,  	 ,	O
56 	56 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
radiation  	radiation  	 NN	B-NP
oncologists  	oncologists  	 NNS	I-NP
would  	would  	 MD	O
not  	not  	 RB	O
change  	change  	 VB	O
their  	their  	 PRP$	O
clinical  	clinical  	 JJ	B-NP
practice  	practice  	 NN	I-NP
to  	to  	 TO	O
include  	include  	 VB	O
hippocampus  	hippocampus  	 JJ	B-NP
sparing  	sparing  	 JJ	I-NP
IMRT  	IMRT  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	B-NP
WBRT  	WBRT  	 NNS	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
RTOG  	RTOG  	 NNP	B-NP
0933 	0933 	 CD	O
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
validation  	validation  	 NN	I-NP
of  	of  	 IN	I-NP
hippocampus  	hippocampus  	 JJ	I-NP
sparing  	sparing  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trial  	trial  	 NN	O
was  	was  	 VBD	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
71 	71 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
radiation  	radiation  	 NN	B-NP
oncologists 	oncologists 	 NN	I-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
further  	further  	 JJ	O
exploration  	exploration  	 NN	O
of  	of  	 IN	O
Memantine  	Memantine  	 NNP	B-NP
for  	for  	 IN	O
this  	this  	 DT	O
purpose  	purpose  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trial  	trial  	 NN	O
was  	was  	 VBD	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
42 	42 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
At  	At  	 IN	O
this  	this  	 DT	O
time 	time 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
surveyed  	surveyed  	 JJ	O
radiation  	radiation  	 NN	B-NP
oncologists  	oncologists  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
US  	US  	 NNP	O
do  	do  	 VBP	O
not  	not  	 RB	O
use  	use  	 VB	O
Memantine 	Memantine 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
IMRT  	IMRT  	 NNP	B-NP
planning  	planning  	 NN	I-NP
for  	for  	 IN	I-NP
hippocampus  	hippocampus  	 JJ	I-NP
sparing  	sparing  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	B-NP
WBRT 	WBRT 	 NNP	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
validation  	validation  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
hippocampus  	hippocampus  	 JJ	I-NP
sparing  	sparing  	 JJ	I-NP
concept  	concept  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trial  	trial  	 NN	O
was  	was  	 VBD	O
supported 	supported 	 VBN	O
,  	,  	 ,	O
before  	before  	 IN	O
adopting  	adopting  	 VBG	O
it  	it  	 PRP	O
in  	in  	 IN	O
routine  	routine  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
practice 	practice 	 NN	I-NP
.  	.  	 .	O
